Latest California Healthline Stories
Alice Ollstein of Politico, Kimberly Leonard of the Washington Examiner and Anna Edney of Bloomberg News join KHN’s Julie Rovner to discuss the latest national health spending estimates, another FDA crackdown on dietary supplements and lawsuits between insurers and the federal government that could result in a windfall for consumers.
In an emerging new tactic against the rising toll of opioid deaths, California, Ohio, Virginia and Arizona are among the states requiring physicians to offer patients naloxone when they give them prescriptions for the powerful painkillers. The Food and Drug Administration is weighing a national recommendation to do so.
Support for “Medicare-for-all” is becoming a front-runner topic among Democratic presidential candidates. But the phrase is being used to describe any number of policies.
Inspired by Los Angeles teachers, who were promised 300 more school nurses after striking last month, unions in Denver, Oakland, Calif., and beyond are demanding more school nurses or better compensation for them.
Only a small percentage of people who survived an opioid overdose received in the next year some form of drug abuse treatment, according to an analysis of West Virginia Medicaid claims data. Experts say the findings underscore a national disconnect.
California’s highly touted gains in vaccinating school children against measles stalled last year, possibly related to an increase in the number of students who have been exempted from vaccinations on medical grounds.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Innovations to help consumers manage their health were on display at the nation’s largest health technology conference that attracted more than 40,000 health industry professionals to Orlando.
A significant portion of syphilis transmission in heterosexuals occurs among people who use drugs, particularly methamphetamine, a new report shows. Public health officials warn that you can’t treat one problem without addressing the other.
President Donald Trump wants Congress to allot $500 million over 10 years for pediatric cancer research. While it’s welcomed by researchers and advocates, it’s not a lot of money.